Jazz Pharmaceuticals plc Stock Price and Value Analysis

Should you buy Jazz Pharmaceuticals plc stock? (NasdaqGS:JAZZ). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the JAZZ Numbers

JAZZ Price
(Jazz Pharmaceuticals plc stock price per share)
[?] JAZZ Fair Price
(based on intrinsic value)
[?] JAZZ Safety Price (based on a variable margin of safety) $65.33
[?] PE Ratio versus Sector 31% lower than other Healthcare stocks
[?] PE Ratio versus Industry 76% lower than other Biotechnology stocks
[?] Cash Yield 6.08%
[?] Free Cash Flow Jitter 56%

Is Jazz Pharmaceuticals plc Stock on Sale?

We believe that Jazz Pharmaceuticals plc may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Jazz Pharmaceuticals plc looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy JAZZ Stock?

Does Jazz Pharmaceuticals plc have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.